Immunome, Inc. (IMNM) Operating margin 2023–2025
Immunome, Inc. (IMNM) operating margin by fiscal year — reported operating income divided by reported revenue.
-3228.8%FY2025 · since FY2023: -781.4% → -3228.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -3228.8% | +153.5 pp |
| FY2024 | -3382.4% | -2601.0 pp |
| FY2023 | -781.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More IMNM financial trends
IMNM RevenueIMNM Net incomeIMNM Net marginIMNM Gross profitIMNM Gross marginIMNM Operating incomeIMNM Operating cash flowIMNM Free cash flowIMNM Capital expendituresIMNM Return on equityIMNM Stock buybacksIMNM Dividends paidIMNM Total assetsIMNM Total liabilitiesIMNM Shareholders’ equityIMNM overview →